Praetorian PR LLC
- SEC CIK
- 0001949877
- Latest filing
- Aug 14, 2026
The latest 13F from Praetorian PR LLC covers Q2 2026 (filed Aug 14, 2026): 14 long positions worth $313.8M. The top 10 holdings make up 97.2% of the portfolio, and the largest is Sprott Inc. (SII) at 19.7%. Livermore has 16 filings on Form 13F from this institution, going back to Q1 2023.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 3
- Est. +$4.98M
- Added
- 7
- Est. +$43.3M
- Reduced
- 0
- Sold out
- 1
- Est. −$2.85M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $313.8M
- +$38.9M (+14.2%) vs. prior quarter
- Positions
- 14
- +2 vs. prior quarter
- Top 10 concentration
- 97.2%
- Top 10 as share of value
- Turnover
- 1.0%
- Q2 2026, one quarter
- Average holding period
- 6.0 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2023), so positions held before then are understated.
13F filings by quarter
14 quarters, going back to Q1 2023. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $313.8M (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | 14 | $313.8M | SIIUTIJOE | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 12 | $274.9M | SIIJOEUTI | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 16 | $206.4M | SIIJOEMRX | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 12 | $165.0M | SIIJOEXP | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 9 | $108.1M | SIIJOEXP | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 18 | $219.9M | VALJOESII | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 19 | $244.3M | VALJOEGOLD | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 13 | $255.1M | GOLDVALJOE | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 14, 2024 | 16 | $272.1M | VALJOEGOLD | vs. Q1 2024 | SEC |
| Q1 2024 | May 15, 2024 | 20 | $312.9M | VALJOETDW | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 12 | $202.2M | JOEVALGOLD | vs. Q3 2023 | SEC |
| Q3 2023 | Jan 26, 2024Amended | 24 | $196.1M | JOEVALTDW | vs. Q2 2023 | SECSEC |
| Q2 2023 | Jan 26, 2024Amended | 25 | $165.5M | JOEVALTDW | vs. Q1 2023 | SECSEC |
| Q1 2023 | May 8, 2023 | 16 | $135.2M | JOEBNOVAL | – | SEC |
13D and 13G filings
Companies where Praetorian PR LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
Praetorian PR LLC does not currently report owning 5% or more of any company.
Latest filings
9 filings on file made by Praetorian PR LLC or listing it as a reporting person, newest first.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| INMBInmune Bio, Inc. | Aug 14, 202512:30 PM ET | 13G/A | 3.40%921.2K shares | −3.80 ppfrom 7.20%Below 5% | Jun 30, 2025 | SEC |
| INMBInmune Bio, Inc. | Apr 10, 202511:26 AM ET | 13G/A | 7.20%1.66M shares | +1.70 ppfrom 5.50% | Mar 31, 2025 | SEC |
| LEELee Enterprises, Inc | Mar 5, 20256:00 PM ET | 13D/A | 4.70%291.0K shares | –Below 5% | Mar 3, 2025 | SEC |
| GOLDGold.com, Inc. | Feb 14, 20254:16 PM ET | 13G/A | 4.60%1.06M shares | –Below 5% | Dec 31, 2024 | SEC |
| INMBInmune Bio, Inc. | Jan 15, 20253:41 PM ET | 13G | 5.50%1.24M shares | New | Jan 15, 2025 | SEC |
| HKHCHorizon Kinetics Holding Corp | May 13, 2024 | 13GOld format | – | New | – | SEC |
| GOLDGold.com, Inc. | Apr 5, 2024 | 13GOld format | – | New | – | SEC |
| GENKGEN Restaurant Group, Inc. | Mar 15, 2024 | 13GOld format | – | New | – | SEC |
| LEELee Enterprises, Inc | Jan 17, 2023 | 13D/AOld format | – | – | – | SEC |